Literature DB >> 17448113

The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts.

Mark Aplin1, Gitte Lund Christensen, Mikael Schneider, Arne Heydorn, Steen Gammeltoft, Anne Louise Kjølbye, Søren P Sheikh, Jakob Lerche Hansen.   

Abstract

The angiotensin II (AngII) type 1 receptor (AT(1)R) has been shown to activate extracellular signal-regulated kinases 1 and 2 (ERK1/2) through G proteins or G protein-independently through beta-arrestin2 in cellular expression systems. As activation mechanisms may greatly influence the biological effects of ERK1/2 activity, differential activation of the AT(1)R in its native cellular context could have important biological and pharmacological implications. To examine if AT(1)R activates ERK1/2 by G protein-independent mechanisms in the heart, we used the [Sar(1), Ile(4), Ile(8)]-AngII ([SII] AngII) analogue in native preparations of cardiac myocytes and beating hearts. We found that [SII] AngII does not activate G(q)-coupling, yet stimulates the beta-arrestin2-dependent ERK1/2. The G(q)-activated pool of ERK1/2 rapidly translocates to the nucleus, while the beta-arrestin2-scaffolded pool remains in the cytosol. Similar biased agonism was achieved in Langendorff-perfused hearts, where both agonists elicit ERK1/2 phosphorylation, but [SII] AngII induces neither inotropic nor chronotropic effects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448113     DOI: 10.1111/j.1742-7843.2007.00063.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  28 in total

1.  Deciphering biased-agonism complexity reveals a new active AT1 receptor entity.

Authors:  Aude Saulière; Morgane Bellot; Hervé Paris; Colette Denis; Frédéric Finana; Jonas T Hansen; Marie-Françoise Altié; Marie-Hélène Seguelas; Atul Pathak; Jakob L Hansen; Jean-Michel Sénard; Céline Galés
Journal:  Nat Chem Biol       Date:  2012-05-27       Impact factor: 15.040

Review 2.  Β-arrestin: a signaling molecule and potential therapeutic target for heart failure.

Authors:  Nabila Noor; Chetan B Patel; Howard A Rockman
Journal:  J Mol Cell Cardiol       Date:  2010-11-11       Impact factor: 5.000

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

Review 4.  Beta-arrestins and heterotrimeric G-proteins: collaborators and competitors in signal transduction.

Authors:  K Defea
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

5.  Biased for benefit: Stimulating the world's most popular drug targets with more nuance.

Authors:  Dyani Lewis
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

6.  Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists.

Authors:  Gitte L Christensen; Christian D Kelstrup; Christina Lyngsø; Uzma Sarwar; Rikke Bøgebo; Søren P Sheikh; Steen Gammeltoft; Jesper V Olsen; Jakob L Hansen
Journal:  Mol Cell Proteomics       Date:  2010-04-02       Impact factor: 5.911

7.  Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes.

Authors:  Pia Lindgren Jeppesen; Gitte Lund Christensen; Mikael Schneider; Anne Yaël Nossent; Hasse Brønnum Jensen; Ditte Caroline Andersen; Tilde Eskildsen; Steen Gammeltoft; Jakob Lerche Hansen; Søren Paludan Sheikh
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

8.  Biased signaling of the angiotensin II type 1 receptor can be mediated through distinct mechanisms.

Authors:  Marie Mi Bonde; Jonas Tind Hansen; Samra Joke Sanni; Stig Haunsø; Steen Gammeltoft; Christina Lyngsø; Jakob Lerche Hansen
Journal:  PLoS One       Date:  2010-11-30       Impact factor: 3.240

9.  β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury.

Authors:  Ki-Seok Kim; Dennis Abraham; Barbara Williams; Jonathan D Violin; Lan Mao; Howard A Rockman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-08-10       Impact factor: 4.733

10.  Exogenous hydrogen sulfide attenuates diabetic myocardial injury through cardiac mitochondrial protection.

Authors:  Xin Zhong; Leihong Wang; Yuwen Wang; Shiyun Dong; Xiaoning Leng; Jing Jia; Yajun Zhao; Hulun Li; Xinying Zhang; Changqing Xu; Guangdong Yang; Lingyun Wu; Rui Wang; Fanghao Lu; Weihua Zhang
Journal:  Mol Cell Biochem       Date:  2012-09-23       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.